Source: Annual Congress 2005 - Tuberculosis, pneumonia and vaccinations
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. A. Eltobgy, F. H. Saleh (Cairo, Egypt; Abu Dhabi, United Arab Emirates). ²Cost analysis of tuberculosis Directly Observed Treatment Strategy (DOTS) at chest dispensaries². Eur Respir J 2005; 26: Suppl. 49, 954

Member's Comments

No comment yet.

Related content which might interest you: A Study on Various Types of Presentations of Paediatric Tuberculosis and Response to  Fixed Dose Combination (FDC). Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020 E-DETECT TB Project: Outreach for Early Tuberculosis Diagnosis Source: ERS webinars 2019 - E-DETECT TB Project: Outreach for Early Tuberculosis Diagnosis Year: 2019 Evaluation of a tuberculosis control programme based on case-finding Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 Monitoring of mycobacterium tuberculosis presence on the objects of TB hospital Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Latent TB infection: Patient choices and completion of treatment Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016 Home based tuberculosis (TB) care program Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Combined collapse therapy in the treatment of cavitary pulmonary tuberculosis (CPTB) Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Efficiency of MDR-TB therapy with the use of thioureidoiminomethylpyridinii perchlorate Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 Improved treatment outcome of MDR-TB in Eastern Taiwan: Reducing default rate by DOTS Plus Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health Year: 2013 Clinical Characteristics and Treatment Outcome of Multidrug-Resistant Tuberculosis (MDR-TB) in a Tertiary Centre in Malaysia: A Two-year Experience Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Selection of patients from Pulmonary Rehabilitation (PR) to Disease Management (DM) programmes Source: International Congress 2017 – Latest insights into the management of chronic lung diseases Year: 2017 Evaluation of 123 Cases with MDR TB (Multidrug Resistant Tuberculosis) Treatment Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 TB or not TB: update from the ERS Respiratory Infection Assembly 10 Source: Eur Respir J 2010; 36: 665-670 Year: 2010 Clinical profile of MDR-TB patients and their early response to DOTS PLUS: An Indian perspective Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 Monitoring during and after tuberculosis treatment Source: Eur Respir Monogr 2018; 82: 308-325 Year: 2018 Collapse therapy in cavitary pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Preventing MDRTB in Europe: Drug sensitivities received after the initial phase of treatment Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016 Steps of bedaquline implementation in Georgia Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016 Treatment of MDR-TB Source: International Congress 2015 – CC1 Diagnosis and management of MDR-TB Year: 2015